Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-30

Clinical Trial Update: Resolvin D1 in Psoriasis Before and After Narrowband UVB Phototherapy [NA]

View source ↗

Summary

A clinical trial update describes testing Resolvin D1 for psoriasis in conjunction with narrowband UVB phototherapy. Phase information is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resolvin-D1 (resolvin-d1)

Snippet

Sponsor: Cairo University | Conditions: Psoriasis | NA | Status: UNKNOWN